effect
→
ReceivesAction
→
studied
|
0.75
|
|
effect
→
ReceivesAction
→
limited
|
0.58
|
|
effect
→
ReceivesAction
→
discussed
|
0.56
|
|
effect
→
ReceivesAction
→
reduced
|
0.53
|
|
effect
→
ReceivesAction
→
felt
|
0.51
|
|
effect
→
ReceivesAction
→
measured
|
0.49
|
|
effect
→
ReceivesAction
→
avoided
|
0.48
|
|
effect
→
ReceivesAction
→
balanced with potential benefits
|
0.43
|
|
effect
→
ReceivesAction
→
associated with therapy
|
0.42
|
|
effect
→
ReceivesAction
→
lived
|
0.41
|
|
effect
→
ReceivesAction
→
considered important
|
0.41
|
|
effect
→
ReceivesAction
→
mediated
|
0.38
|
|
effect
→
ReceivesAction
→
observed
|
0.37
|
|
effect
→
ReceivesAction
→
monitored
|
0.36
|
|
effect
→
ReceivesAction
→
reported
|
0.31
|
|
effect
→
ReceivesAction
→
associated with drug
|
0.29
|
|
effect
→
ReceivesAction
→
achieved
|
0.29
|
|
effect
→
ReceivesAction
→
assessed by coronary angiography
|
0.29
|
|
effect
→
ReceivesAction
→
confirmed
|
0.29
|
|
effect
→
ReceivesAction
→
corroborated by similar findings
|
0.29
|
|
effect
→
ReceivesAction
→
desired
|
0.29
|
|
effect
→
ReceivesAction
→
enhanced
|
0.29
|
|
effect
→
ReceivesAction
→
expected
|
0.29
|
|
effect
→
ReceivesAction
→
maintained
|
0.29
|
|
effect
→
ReceivesAction
→
maintained through 26 weeks
|
0.29
|
|
effect
→
ReceivesAction
→
managed
|
0.29
|
|
effect
→
ReceivesAction
→
related
|
0.29
|
|
effect
→
ReceivesAction
→
studied in 10 healthy subjects
|
0.29
|
|
effect
→
ReceivesAction
→
understood
|
0.27
|
|
effect
→
ReceivesAction
→
associated with chemotherapy
|
0.25
|
|
effect
→
ReceivesAction
→
abrogated
|
0.25
|
|
effect
→
ReceivesAction
→
assessed by b-mode ultrasonogra…
|
0.25
|
|
effect
→
ReceivesAction
→
assessed in 4,444 patients
|
0.25
|
|
effect
→
ReceivesAction
→
assessed in 4s
|
0.25
|
|
effect
→
ReceivesAction
→
compared
|
0.25
|
|
effect
→
ReceivesAction
→
manifested
|
0.25
|
|
effect
→
ReceivesAction
→
observed in peri/postnatal toxi…
|
0.25
|
|
effect
→
ReceivesAction
→
obtained
|
0.25
|
|
effect
→
ReceivesAction
→
quantified
|
0.25
|
|
effect
→
ReceivesAction
→
noted
|
0.20
|
|
effect
→
ReceivesAction
→
detected
|
0.18
|
|
effect
→
ReceivesAction
→
caused by the disease
|
0.16
|
|
effect
→
ReceivesAction
→
likely to occur
|
0.16
|
|
effect
→
ReceivesAction
→
seen for diabetic
|
0.16
|
|
effect
→
ReceivesAction
→
seen in the 2m/kg group
|
0.16
|
|
effect
→
ReceivesAction
→
detected in small clinical trial
|
0.13
|
|
effect
→
ReceivesAction
→
noted at 0.2 mg/kg/day
|
0.09
|
|
effect
→
ReceivesAction
→
noted at maximum recommended hu…
|
0.09
|
|
effect
→
ReceivesAction
→
recorded
|
0.09
|
|
effect
→
ReceivesAction
→
reported with metolazone
|
0.09
|
|